K-numberK251294
Device nameBonafix Implant Abutments
ApplicantZentek Medical, LLC
Product codeNHA
Device classClass II
Decision dateOct 15, 2025
DecisionSubstantially Equivalent
Regulation872.3630
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Bonafix Implant Abutments are dental prosthetic components designed to connect dental implants to tooth crowns or bridges in patients missing one or more teeth. The system includes three types of abutments (Temporary, Multi-Unit Straight, and Titanium Base) and is compatible with 16 different endosseous implant platforms from five manufacturers. All components are provided non-sterile and require end-user steam sterilization before use.

Technological characteristics

The subject device uses titanium alloy (Ti-6Al-4V, ASTM F136) for abutment bodies and screws, with zirconia (ISO 13356) superstructures for the TiBase design. Design parameters include minimum post height of 4.0 mm, maximum gingival height of 5.0 mm, and 0° angulation (no angular correction). Platform diameters range from 3.5–6.3 mm. All characteristics are identical or substantially similar to the predicate device K221673, differing only in the newly added compatible implant systems.

Test standards cited

ISO 17665-1 for sterilization validation (SAL 1×10⁻⁶), ISO 10993-5 for cytotoxicity testing, ASTM F136 for titanium alloy specification, and ISO 13356 for zirconia material. FDA Guidance on Class II Special Controls for endosseous dental implants and abutments, and FDA Guidance on MRI safety testing were applied.

Substantial equivalence argument

Substantial equivalence is supported because the subject device has identical intended use (supporting single or multi-unit prostheses), uses the same operating principles and materials as the predicate, incorporates the same abutment design categories and sterilization processes, and non-clinical testing (sterilization, cytotoxicity, dimensional compatibility analysis, and MRI review) demonstrates equivalent safety and performance. The primary difference—expanded compatible implant systems—does not affect safety or efficacy.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →